PNC Financial Services Group
GNCA

PNC Financial Services Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

PNC Financial Services Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-38
Closed -$2K – 4165
2016
Q3 		$2K Buy
+38
New +$1.49K ﹤0.01% 3854
2014
Q4 		– Sell
-13
Closed -$1K – 4310
2014
Q3 		$1K Hold
13
– – ﹤0.01% 3898
2014
Q2 		$2K Buy
+13
New +$1.97K ﹤0.01% 3584

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

PNC Financial Services Group's GNCA Position: Q4 2016 in Review

PNC Financial Services Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2016, closing a stake of 38 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in GNCA in Q2 2014 and held it in 3 quarters. The position peaked at $2K in Q3 2016. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

  • PNC Financial Services Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 38 Genocea Biosciences, Inc. shares in Q4 2016, an estimated $2K.
  • PNC Financial Services Group first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 3 quarters.
  • PNC Financial Services Group's Genocea Biosciences, Inc. position peaked at $2K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on PNC Financial Services Group's 13F filing for Q4 2016, filed 10 Feb 2017.